JPRN-UMIN000009565招募中2 期
Pilot study of S-1/Paclitaxel/Trastuzumab combination chemotherapy for HER2-positive Stage IV advanced gastric cancer. - KGCSG1201
Department of Digestive Surgery, Breast and Thyroid Surgery Graduate School of Medical Science Kagoshima University0 个研究点目标入组 20 人开始时间: 2012年12月17日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Forbidden case to use S-1, Paclitaxel and Trastuzumab. 2)Patient who want to be pregnant and /or pregnant woman. Intend to make pregnant. 3)Infection or inflammatory case. 4)Active hepatitis type HBs positive. 5)Severe heart disease. 6)Severe complicated case. 7)Watery diarrhea. 8)Bleeding from tumor or ulceration. 9)Multiple bone metastasis. 10)Clinical suspicion or previous history of metastasis to brain or meninges. 11)Complicated other active cancer. 12)Operated within 28 days. 13)Mental disability requiring medical treatment. 14)Otherwise determined by investigators or site principal investigators to be unsuitable for participation in study.
研究者
相似试验
已完成
1 期
Phase I/II study of Paclitaxel+Trastuzumab therapy in 2nd line treatment for advanced or recurrent gastric cancer with HER2 positive.HER2-positive gastric cancerJPRN-UMIN000011863Osaka Medical College Hospital100
暂停
不适用
Phase I/II Trial of S-1 plus paclitaxel combination chemotherapy in elderly patients with non-small lung canceron-small cell lung cancerJPRN-UMIN000003782Kyoto prefectural University of Medicine45
已完成
2 期
Phase II study of S-1/paclitaxel combination therapy in patients with previously treated non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000035812Kyoto Prefectural University of Medicine45
招募中
1 期
Exploratory study of Paclitaxel+Trastuzumab therapy for advanced or recurrent gastric cancer with HER2 positive.advanced or recurrent HER2-positive gastric cancerJPRN-UMIN000008623The Cancer Institute Hospital of JFCR36
已完成
不适用
A phase II study of paclitaxel plus trastuzumab in patients with pretreated recurrent or metastatic gastric cancer.advanced gastric cancerJPRN-UMIN000006403Toyama Prefectural Central Hospital30